{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:07:01Z","timestamp":1786115221685,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006687","name":"University Claude Bernard Lyon 1","doi-asserted-by":"publisher","award":["SENS 2022"],"award-info":[{"award-number":["SENS 2022"]}],"id":[{"id":"10.13039\/501100006687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003750","name":"French Association for Alzheimer Disease and Similar Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-22-PEBI-0007"],"award-info":[{"award-number":["ANR-22-PEBI-0007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nano.2026.102987","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:48:03Z","timestamp":1783529283000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nose-to-brain delivery of an amyloid beta blocking peptide using polylactic acid-poloxamer 188 nanocarriers"],"prefix":"10.1016","volume":"75","author":[{"given":"Marie","family":"BOLON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"BARBEREAU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"AIMARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"MONGE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"BOUVET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"MEISSIREL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"RICHARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102987_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: a review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"10284","key":"10.1016\/j.nano.2026.102987_bb0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.nano.2026.102987_bb0015","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1093\/brain\/awad159","article-title":"The amyloid cascade hypothesis: an updated critical review","volume":"146","author":"Kepp","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nano.2026.102987_bb0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.nano.2026.102987_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.nano.2026.102987_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.celrep.2021.109121","article-title":"VEGF counteracts amyloid-\u03b2-induced synaptic dysfunction","volume":"35","author":"Martin","year":"2021","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.nano.2026.102987_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13907","article-title":"A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity","volume":"22","author":"Bouvet","year":"2023","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.nano.2026.102987_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4155\/tde-2023-0019","article-title":"Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review","volume":"14","author":"Babu","year":"2023","journal-title":"Ther Deliv"},{"issue":"11","key":"10.1016\/j.nano.2026.102987_bb0045","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/pharmaceutics13111897","article-title":"Nanoparticle-guided brain drug delivery: expanding the therapeutic approach to neurodegenerative diseases","volume":"13","author":"Riccardi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.nano.2026.102987_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms222111654","article-title":"Nanoparticles for targeted brain drug delivery: what do we know?","volume":"22","author":"Pinheiro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102987_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/bdd.2400","article-title":"Exploring the potential of nasal drug delivery for brain targeted therapy: a detailed analysis","author":"Ghosh","year":"2024","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.nano.2026.102987_bb0060","article-title":"Nanotechnology-enabled nose-to-brain delivery: promising strategies for targeting neurological disorders","volume":"9","author":"Saxena","year":"2026","journal-title":"Nanotechnol"},{"key":"10.1016\/j.nano.2026.102987_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.nano.2026.102987_bb0070","first-page":"3","article-title":"Factors affecting nasal drug delivery and design strategies for intranasal drug delivery","volume":"52","author":"Hu","year":"2023","journal-title":"Zhejiang Xue Xue Bao Yi Xue Ban J Zhejiang Univ Med Sci"},{"issue":"31","key":"10.1016\/j.nano.2026.102987_bb0075","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1039\/D5NR00870K","article-title":"Polymeric nanoparticles for efficient nose-to-brain delivery","volume":"17","author":"Bolon","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102987_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122760","article-title":"PEGylated and functionalized polylactide-based nanocapsules: an overview","volume":"636","author":"de Oliveira","year":"2023","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2026.102987_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcis.2006.07.031","article-title":"Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms","volume":"302","author":"Santander-Ortega","year":"2006","journal-title":"J Colloid Interface Sci"},{"issue":"37","key":"10.1016\/j.nano.2026.102987_bb0090","doi-asserted-by":"crossref","first-page":"11674","DOI":"10.1039\/D5TB00947B","article-title":"Polymeric nanoparticles as a platform for nose-to-brain delivery","volume":"13","author":"Bolon","year":"2025","journal-title":"J Mater Chem B"},{"issue":"3","key":"10.1016\/j.nano.2026.102987_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/pharmaceutics13030377","article-title":"LipoParticles: lipid-coated PLA nanoparticles enhanced in vitro mRNA transfection compared to liposomes","volume":"13","author":"Ayad","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.nano.2026.102987_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/molecules28124778","article-title":"Poloxamers have vaccine-adjuvant properties by increasing dissemination of particulate antigen at distant lymph nodes","volume":"28","author":"Lamrayah","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.nano.2026.102987_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13346-020-00816-2","article-title":"Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating","volume":"10","author":"de Oliveira Junior","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"12","key":"10.1016\/j.nano.2026.102987_bb0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/17425247.2019.1690452","article-title":"In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles","volume":"16","author":"Cayero-Otero","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"issue":"13","key":"10.1016\/j.nano.2026.102987_bb0115","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.nano.2026.102987_bb0120","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1002\/cpcb.51","article-title":"Transcription factor-mediated differentiation of human iPSCs into neurons","volume":"79","author":"Fernandopulle","year":"2018","journal-title":"Curr Protoc Cell Biol"},{"issue":"2","key":"10.1016\/j.nano.2026.102987_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jnc.14936","article-title":"Respiratory syncytial virus tropism for olfactory sensory neurons in mice","volume":"155","author":"Bryche","year":"2020","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.nano.2026.102987_bb0130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.nano.2026.102987_bb0135","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.nano.2026.102987_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15252\/emmm.201606666","article-title":"An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice","volume":"9","author":"Cheng","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.nano.2026.102987_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-025-00481-w","article-title":"Nose-to-brain drug delivery: from bench to bedside","volume":"14","author":"Drath","year":"2025","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.nano.2026.102987_bb0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17425247.2024.2339335","article-title":"Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier","volume":"21","author":"Hua","year":"2024","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.nano.2026.102987_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00018-007-7288-3","article-title":"Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions","volume":"65","author":"Wang","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nano.2026.102987_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.12.029","article-title":"Effect of PLGA NP size on efficiency to target traumatic brain injury","volume":"223","author":"Cruz","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102987_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.colsurfb.2017.03.035","article-title":"Nose to brain delivery in rats: effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization","volume":"154","author":"Bonaccorso","year":"2017","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"3","key":"10.1016\/j.nano.2026.102987_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.nano.2026.102987_bb0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"19","author":"Trejo-Lopez","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"10.1016\/j.nano.2026.102987_bb0180","first-page":"13","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102987_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105208","article-title":"Aggregation and structure of amyloid \u03b2-protein","volume":"151","author":"Ono","year":"2021","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.nano.2026.102987_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13195-025-01812-9","article-title":"Aducanumab binds high molecular weight soluble A\u03b2 oligomers and restores intracellular calcium levels","volume":"17","author":"Yu","year":"2025","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"2","key":"10.1016\/j.nano.2026.102987_bb0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ymthe.2022.11.002","article-title":"AAV-mediated neuronal expression of an scFv antibody selective for a\u03b2 oligomers protects synapses and rescues memory in Alzheimer models","volume":"31","author":"Selles","year":"2023","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"8","key":"10.1016\/j.nano.2026.102987_bb0200","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1096\/fj.201900604R","article-title":"High molecular weight amyloid \u03b21-42 oligomers induce neurotoxicity via plasma membrane damage","volume":"33","author":"Yasumoto","year":"2019","journal-title":"FASEB J"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:45:50Z","timestamp":1785977150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S1549963426000882"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102987","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of an amyloid beta blocking peptide using polylactic acid-poloxamer 188 nanocarriers","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}